SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YellowLegalPad
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: John McCarthy7/18/2007 6:45:25 PM
   of 1182
 
Ignore -

=================================

CancerCat:Brain
DrugName:Autologous Tumor Lysate-Pulsed Dendritic Cell
VacTypeDesc:Dendritic Cell

CompName:
Hosp - Jonsson Comprehensive Cancer Center

TrialName:
Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma

Trial Number:NCT00107185
Phase:1
Enroll:18
VacTrialID:3
TrialLink:http://clinicaltrials.gov/ct/show/NCT00107185?order=1

DrugLink:
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Brain
DrugName:Autologous Tumor Lysate-Pulsed Dendritic Cell
VacTypeDesc:Dendritic Cell

CompName:
Hosp - Jonsson Comprehensive Cancer Center

TrialName:
Vaccine Therapy in Treating Patients With Malignant Glioma

Trial Number:NCT00068510
Phase:1
Enroll:18
VacTrialID:2
TrialLink:http://clinicaltrials.gov/ct/show/NCT00068510?order=2

DrugLink:
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Brain
DrugName:DCVAX-Brian
VacTypeDesc:Dendritic Cell

CompName:
Northwest Biotherapeutics Inc

TrialName:
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer

Trial Number:NCT00045968
Phase:2
Enroll:141
VacTrialID:1
TrialLink:http://clinicaltrials.gov/ct/show/NCT00045968?order=1

DrugLink:http://www.nwbio.com/dcvax_brain.php
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Brain
DrugName:Oncophage
VacTypeDesc:Heat Shock Protein

CompName:
Antigenics

TrialName:
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma

Trial Number:NCT00293423
Phase:1
Enroll:50
VacTrialID:21
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00293423?order=1

DrugLink:http://www.antigenics.com/products/cancer/oncophage/
DrugPatentLink:
PriorTrialLink:http://pub.ucsf.edu/newsservices/releases/200704171/
PriorTrialLink1:http://www.caring4cancer.com/go/kidney/news?NewsItemId=20070416elin011.xml
PartnerID:
PartnerLink:
Commentary:http://www.abc.net.au/rn/healthreport/stories/2007/1867372.htm

=================================
CancerCat:Brain
DrugName:Cotara
VacTypeDesc:Non-Vaccine - Cotara - TNT (tumor necrosis therpy)

CompName:
Peregrine Pharmaceuticals

TrialName:
Brain Cancer - Glioblastoma

Trial Number:Cotara - India
Phase:2
Enroll:40
VacTrialID:10
TrialLink:http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/06-25-2007/0004614602&EDATE=

DrugLink:
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Brain
DrugName:CDX-110
VacTypeDesc:Peptide

CompName:
Celldex Therapeutics

TrialName:
Phase II/III Study of CDX-110 in Patients With GBM (ACT III)

Trial Number:NCT00458601
Phase:3
Enroll:375
VacTrialID:22
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00458601?order=1

DrugLink:http://www.celldextherapeutics.com/wt/page/cdx_110
DrugPatentLink:http://www.freshpatents.com/Egfrviii-specific-monoclonal-antibody-and-egfrviii-ribozymes-and-use-to-detect-treat-or-prevent-egfrviii-associated-cancer-dt20051006ptan20050222059.php
PriorTrialLink:http://www.biospace.com/news_story.aspx?NewsEntityId=58603
PriorTrialLink1:http://www.genengnews.com/news/bnitem.aspx?name=18403748&taxid=29
PartnerID:
PartnerLink:
Commentary:http://sanjose.bizjournals.com/sanjose/stories/2007/04/09/story4.html

=================================
CancerCat:Brain
DrugName:HER-2/Neu Pulsed DC1 Vaccine
VacTypeDesc:Peptide

CompName:
Hosp - University of Pennsylvania - Dr. Czerniecki

TrialName:
Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast

Trial Number:NCT00107211
Phase:1
Enroll:30
VacTrialID:4
TrialLink:http://clinicaltrials.gov/ct/show/NCT00107211?order=3

DrugLink:
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Brain
DrugName:NV1020 - Oncolytic Virus
VacTypeDesc:Virus

CompName:
MediGene AG

TrialName:
Brain Cancer - Glioblastoma

Trial Number:NV1020-Glioblastoma - Not Started
Phase:0
Enroll:0
VacTrialID:8
TrialLink:http://www.labtechnologist.com/news/ng.asp?n=78088-medigene-herpes-cancer-virus-tumours

DrugLink:http://www.medigene.de/englisch/ProjektHSV.php
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Breast Cancer
DrugName:TroVax
VacTypeDesc:Antigen

CompName:
Oxford BioMedica

TrialName:
Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission

Trial Number:NCT00227474
Phase:2
Enroll:120
VacTrialID:18
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00227474?order=3

DrugLink:http://www.oxfordbiomedica.co.uk/trovax.htm
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:SNY
PartnerLink:
Commentary:

=================================
CancerCat:Colorectal Cancer
DrugName:NV1020 - Oncolytic Virus
VacTypeDesc:Virus

CompName:
MediGene AG

TrialName:
Safety and Efficacy of a Genetically Engineered Herpes Simplex Virus NV1020 to Treat Colorectal Cancer Metastatic to Liver

Trial Number:NCT00149396
NCT00149396
Phase:2
Enroll:27
VacTrialID:7
TrialLink:http://clinicaltrials.gov/ct/show/NCT00149396?order=1

DrugLink:
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Head and Neck
DrugName:MAGE-A3
VacTypeDesc:Antigen

CompName:
GlaxoSmithKline

TrialName:
MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck

Trial Number:NCT00257738
Phase:1
Enroll:90
VacTrialID:19
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00257738?order=1

DrugLink:http://www.gsk-us.com/ControllerServlet?appId=4&pageId=402&newsid=910
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Lung Cancer
DrugName:MAGE-A3
VacTypeDesc:Antigen

CompName:
GlaxoSmithKline

TrialName:
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer

Trial Number:NCT00480025
Phase:3
Enroll:2270
VacTrialID:15
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00480025?order=3

DrugLink:http://www.medicalnewstoday.com/articles/73327.php
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Lung Cancer
DrugName:Stimuvax
VacTypeDesc:Tumor Cell - Autologous

CompName:
Merck KGaA

TrialName:
Cancer Vaccine Study for Unresectable Stage III Non-Small Cell Lung Cancer

Trial Number:NCT00409188
Phase:3
Enroll:1322
VacTrialID:14
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00409188?order=1

DrugLink:http://www.biomira.com/professionals/biomiraVaccines/BLP25/
DrugPatentLink:
PriorTrialLink:http://www.biomira.com/pipeline/stimuvax/
PriorTrialLink1:http://www.psa-rising.com/wiredbird/biomira_stimuvax06.html
PartnerID:BIOM
PartnerLink:http://www.healthcare-digital.co.uk/Biomira-announces-new-COO_1116.aspx
Commentary:http://www.biomira.com/pipeline/stimuvax/

=================================
CancerCat:Lung Cancer
DrugName:VaxImmune
VacTypeDesc:Vaccine Adjuvant - VaxImmune

CompName:
Coley Pharmaceutical

TrialName:
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer

Trial Number:NCT00480025
Phase:3
Enroll:2270
VacTrialID:20
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00480025?order=3

DrugLink:http://money.aol.com/news/articles/_a/coley-pharmaceutical-groups-vaccine/n20070605095209990013
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Melanoma
DrugName:UVIDEM (IDD-3)
VacTypeDesc:Dendritic Cell

CompName:
IDM Pharma, Inc.

TrialName:
Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma

Trial Number:NCT00107159
Phase:2
Enroll:30
VacTrialID:5
TrialLink:http://clinicaltrials.gov/ct/show/NCT00107159?order=1

DrugLink:
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:SNY
PartnerLink:
Commentary:

=================================
CancerCat:Ovarian Cancer
DrugName:Abagovomab
VacTypeDesc:Anti-Idiotype

CompName:
Menarini Group

TrialName:
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients (MIMOSA)

Trial Number:NCT00418574
Phase:3
Enroll:870
VacTrialID:13
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00418574?order=1

DrugLink:
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Pancreatic
DrugName:GV1001
VacTypeDesc:Peptide

CompName:
Pharmexa A/S

TrialName:
Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Trial Number:NCT00425360
Phase:3
Enroll:1110
VacTrialID:12
TrialLink:http://clinicaltrials.gov/ct/show/NCT00425360?order=3

DrugLink:http://www.pharmexa.com/site.asp?p=506
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Pancreatic
DrugName:GV1001
VacTypeDesc:Peptide

CompName:
Pharmexa A/S

TrialName:
GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer.
`

Trial Number:NCT00358566
Phase:3
Enroll:520
VacTrialID:6
TrialLink:http://clinicaltrials.gov/ct/show/NCT00358566?order=1

DrugLink:http://www.pharmexa.com/site.asp?p=506
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Prostate
DrugName:VPM4001
VacTypeDesc:Tumor Cell - Allogeneic

CompName:
Vakzine Projekt Management

TrialName:
Phase I/II Prostate Cancer

Trial Number:Unknown
Phase:2
Enroll:30
VacTrialID:23
TrialLink:http://www.psa-rising.com/wiredbird/vakzinepm0607.html

DrugLink:http://www.vakzine-manager.de/Allogeneic_Cancer_Va.167.0.html?&L=1#553
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Renal Cell Carcinoma
DrugName:TroVax
VacTypeDesc:Antigen

CompName:
Oxford BioMedica

TrialName:
TroVax Renal Immunotherapy Survival Trial

Trial Number:NCT00397345
Phase:3
Enroll:700
VacTrialID:16
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00397345?order=1

DrugLink:http://www.oxfordbiomedica.co.uk/trovax.htm
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:SNY
PartnerLink:http://www.drugresearcher.com/news/ng.asp?n=75395-sanofi-aventis-oxford-biomedica-trovax-cancer-vaccine-glaxosmithkline
Commentary:

=================================
CancerCat:Renal Cell Carcinoma
DrugName:TroVax
VacTypeDesc:Antigen

CompName:
Oxford BioMedica

TrialName:
A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer

Trial Number:NCT00083941
Phase:2
Enroll:25
VacTrialID:17
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00083941?order=2

DrugLink:http://www.oxfordbiomedica.co.uk/trovax.htm
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:SNY
PartnerLink:
Commentary:

=================================

KEYWORD:
CANCER
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News